Impact of Metaiodobenzylguanidine Scintigraphy on Assessing Response of High-Risk Neuroblastoma to Dose-Intensive Induction Chemotherapy
- 15 March 2003
- journal article
- pediatric oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (6) , 1082-1086
- https://doi.org/10.1200/jco.2003.07.142
Abstract
Purpose: The International Neuroblastoma Response Criteria (INRC) recommend, but do not make mandatory, metaiodobenzylguanidine (MIBG) scans. We present the first report on the effect of MIBG scans...Keywords
This publication has 34 references indexed in Scilit:
- Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumorsMedical and Pediatric Oncology, 2000
- The Impact of123I-Meta-Iodobenzylguanidine Scintigraphy on Diagnostics and Follow-up of NeuroblastomaActa Oncologica, 1995
- A new 123I-MIBG whole body scan scoring method—Application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastomaEuropean Journal Of Cancer, 1995
- Meta-iodobenzylguanidine in childrenSeminars in Nuclear Medicine, 1993
- Efficacy of Metaiodobenzylguanidine as a Scintigraphic Agent for the Detection of NeuroblastomaInvestigative Radiology, 1992
- High-dose rapid schedule chemotherapy for disseminated neuroblastomaEuropean Journal Of Cancer, 1992
- A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/cytology in neuroblastomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Consolidating the role of*I-MIBG-scintigraphy in childhood neuroblastoma: Five years of clinical experiencePediatric Radiology, 1990
- Radio-iodobenzylguanidine scintigraphy of neuroblastoma: Conflicting results, when compared with standard investigationsMedical and Pediatric Oncology, 1989
- Correlation Between lodine-131 MIBG Imaging and Biological Markers in Advanced NeuroblastomaClinical Nuclear Medicine, 1988